Ultimately, celastrol prevented the formation of human HCC xenograft tumors in athymic nu/nu mice and reduced STAT3 activation in tumor tissues when administered intraperitoneally without causing any adverse effects [90]. The gene discussed is STAT3; the disease is hepatocellular carcinoma.